Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Benhamou

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Journal of Hepatology|July 26, 2011
Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysisPatrick Ingiliz, Marc-Antoine Valantin, Paul Preziosi, et al.
The Journal of Antimicrobial Chemotherapy|September 4, 2010
Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE studyStephanie Dominguez, Jade Ghosn, Gilles Peytavin, et al.
World Journal of Gastroenterology|July 18, 2009
Applicability and variability of liver stiffness measurements according to probe positionPatrick Ingiliz, Kim Pav Chhay, Mona Munteanu, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patientsYves Benhamou, Herve Fleury, Pascale Trimoulet, et al.
European Journal of Gastroenterology & Hepatology|November 18, 2008
The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumptionFrançoise Imbert-Bismut, Sylvie Naveau, Rachel Morra, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|July 2, 2009
Assessment of liver fibrosis: noninvasive meansThierry Poynard, Rachel Morra, Patrick Ingiliz, et al.
Hepatology (Baltimore, Md.)|July 9, 2009
A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 resultsYves Benhamou, Nezam H Afdhal, David R Nelson, et al.
Diabetes & Metabolism|November 3, 2021
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort surveyEmilie Deberles, Remy Morello, Juliette Hardouin, et al.
Journal of Hepatology|May 19, 2009
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis CAvidan U Neumann, Stephen Pianko, Stefan Zeuzem, et al.
AIDS (London, England)|March 21, 2003
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patientsRobert P Myers, Yves Benhamou, Françoise Imbert-Bismut, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|July 26, 2011
Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysisPatrick Ingiliz, Marc-Antoine Valantin, Paul Preziosi, et al.
The Journal of Antimicrobial Chemotherapy|September 4, 2010
Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE studyStephanie Dominguez, Jade Ghosn, Gilles Peytavin, et al.
World Journal of Gastroenterology|July 18, 2009
Applicability and variability of liver stiffness measurements according to probe positionPatrick Ingiliz, Kim Pav Chhay, Mona Munteanu, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patientsYves Benhamou, Herve Fleury, Pascale Trimoulet, et al.
European Journal of Gastroenterology & Hepatology|November 18, 2008
The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumptionFrançoise Imbert-Bismut, Sylvie Naveau, Rachel Morra, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|July 2, 2009
Assessment of liver fibrosis: noninvasive meansThierry Poynard, Rachel Morra, Patrick Ingiliz, et al.
Hepatology (Baltimore, Md.)|July 9, 2009
A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 resultsYves Benhamou, Nezam H Afdhal, David R Nelson, et al.
Diabetes & Metabolism|November 3, 2021
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort surveyEmilie Deberles, Remy Morello, Juliette Hardouin, et al.
Journal of Hepatology|May 19, 2009
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis CAvidan U Neumann, Stephen Pianko, Stefan Zeuzem, et al.
AIDS (London, England)|March 21, 2003
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patientsRobert P Myers, Yves Benhamou, Françoise Imbert-Bismut, et al.
Pageof 17